Literature DB >> 24322895

Neural stem cell therapies for enteric nervous system disorders.

Alan J Burns1, Nikhil Thapar2.   

Abstract

The enteric nervous system is vulnerable to a range of congenital and acquired disorders that disrupt the function of its neurons or lead to their loss. The resulting enteric neuropathies are some of the most challenging clinical conditions to manage. Neural stem cells offer the prospect of a cure given their potential ability to replenish missing or dysfunctional neurons. This article discusses diseases that might be targets for stem cell therapies and the barriers that could limit treatment application. We explore various sources of stem cells and the proof of concept for their use. The critical steps that remain to be addressed before these therapies can be used in patients are also discussed. Key milestones include the harvesting of neural stem cells from the human gut and the latest in vivo transplantation studies in animals. The tremendous progress in the field has brought experimental studies exploring the potential of stem cell therapies for the management of enteric neuropathies to the cusp of clinical application.

Entities:  

Mesh:

Year:  2013        PMID: 24322895     DOI: 10.1038/nrgastro.2013.226

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  40 in total

1.  Increased Fibronectin Impairs the Function of Excitatory/Inhibitory Synapses in Hirschsprung Disease.

Authors:  Ni Gao; Peimin Hou; Jian Wang; Tingting Zhou; Dongming Wang; Qiangye Zhang; Weijing Mu; Xiaona Lv; Aiwu Li
Journal:  Cell Mol Neurobiol       Date:  2019-11-23       Impact factor: 5.046

2.  The appendix as a viable source of neural progenitor cells to functionally innervate bioengineered gastrointestinal smooth muscle tissues.

Authors:  Elie Zakhem; Stephen L Rego; Shreya Raghavan; Khalil N Bitar
Journal:  Stem Cells Transl Med       Date:  2015-04-14       Impact factor: 6.940

Review 3.  Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes.

Authors:  Robert O Heuckeroth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-04       Impact factor: 46.802

Review 4.  Building a second brain in the bowel.

Authors:  Marina Avetisyan; Ellen Merrick Schill; Robert O Heuckeroth
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

5.  Delivery of enteric neural progenitors with 5-HT4 agonist-loaded nanoparticles and thermosensitive hydrogel enhances cell proliferation and differentiation following transplantation in vivo.

Authors:  Ryo Hotta; Lily Cheng; Hannah K Graham; Nandor Nagy; Jaime Belkind-Gerson; George Mattheolabakis; Mansoor M Amiji; Allan M Goldstein
Journal:  Biomaterials       Date:  2016-02-17       Impact factor: 12.479

6.  Regeneration: Stem cells make the bowel nervous.

Authors:  Robert O Heuckeroth
Journal:  Nature       Date:  2016-02-10       Impact factor: 49.962

Review 7.  Diabetes and the Small Intestine.

Authors:  Jonathan Gotfried; Stephen Priest; Ron Schey
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

Review 8.  Optogenetic and chemogenetic techniques for neurogastroenterology.

Authors:  Werend Boesmans; Marlene M Hao; Pieter Vanden Berghe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-29       Impact factor: 46.802

9.  A collagen VI-dependent pathogenic mechanism for Hirschsprung's disease.

Authors:  Rodolphe Soret; Mathilde Mennetrey; Karl F Bergeron; Anne Dariel; Michel Neunlist; Franziska Grunder; Christophe Faure; David W Silversides; Nicolas Pilon
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

Review 10.  Stem cell-based therapy for hirschsprung disease, do we have the guts to treat?

Authors:  Ali Fouad Alhawaj
Journal:  Gene Ther       Date:  2021-06-14       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.